Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.
D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D002140:California; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D009362:Neoplasm Metastasis
D004317:Doxorubicin; C030851:esorubicin